Carregant...
The combined presence of CD20+ B cells and PD-L1+ tumor infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
PURPOSE: To evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. METHODS: PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L...
Guardat en:
| Publicat a: | Breast Cancer Res Treat |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6173952/ https://ncbi.nlm.nih.gov/pubmed/29858752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4834-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|